Bian K, Harari Y, Zhong M, Lai M, Castro G, Weisbrodt N, Murad F
Department of Integrative Biology and Pharmacology, The University of Texas-Houston Medical School, Houston, Texas 77030-0708, USA.
Mol Pharmacol. 2001 Apr;59(4):939-47. doi: 10.1124/mol.59.4.939.
Nitric oxide (NO) possesses potent anti-inflammatory properties; however, an over-production of NO will promote inflammation and induce cell and tissue dysfunction. Thus, the ability to precisely regulate NO production could prove beneficial in controlling damage. In this study, advantage was taken of the well characterized inflammatory response caused by an intestinal parasite, Trichinella spiralis, to study the relationship between intestinal inflammation and the regulation of nitric oxide synthase-type 2 (NOS-2) expression. Our study revealed that a specific gut inflammatory reaction results in inhibition of NOS-2 expression. Characteristics of this inhibition are: 1) local jejunal inflammation induced by T. spiralis systemically inhibits NOS-2 gene transcription, protein expression, and enzyme activity; 2) the inhibition blunts endotoxin-stimulated NOS-2 expression; 3) the inhibition does not extend to the expression of other isoforms of NOS, to paxillin, a housekeeper protein, or to cyclooxygenase-2, another protein induced by proinflammatory cytokines; 4) the inhibition is unlikely related to the formation of specific anti-parasite antibodies; and 5) the inhibition may involve substances other than stress-induced corticosteroids. Elucidation of such potent endogenous NOS-2 down-regulatory mechanisms could lead to the development of new strategies for the therapy of inflammatory conditions characterized by the overproduction of NO.
一氧化氮(NO)具有强大的抗炎特性;然而,NO的过度产生会促进炎症并导致细胞和组织功能障碍。因此,精确调节NO产生的能力可能对控制损伤有益。在本研究中,利用肠道寄生虫旋毛虫引起的特征明确的炎症反应,来研究肠道炎症与一氧化氮合酶2型(NOS-2)表达调控之间的关系。我们的研究表明,特定的肠道炎症反应会导致NOS-2表达受到抑制。这种抑制的特点是:1)旋毛虫诱导的局部空肠炎症会系统性地抑制NOS-2基因转录、蛋白质表达和酶活性;2)这种抑制会减弱内毒素刺激的NOS-2表达;3)这种抑制并不扩展到NOS其他同工型、管家蛋白桩蛋白或促炎细胞因子诱导的另一种蛋白质环氧合酶-2的表达;4)这种抑制不太可能与特异性抗寄生虫抗体的形成有关;5)这种抑制可能涉及应激诱导的皮质类固醇以外的物质。阐明这种强大的内源性NOS-2下调机制可能会带来新策略的开发,用于治疗以NO过度产生为特征的炎症性疾病。